Bartolomeo, R.; Troise, F.; Allocca, S.; Sdruscia, G.; Vitale, R.; Bignone, V.; Petrone, A.M.; Romano, G.; D’Alise, A.M.; Ruzza, V.;
et al. Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines 2024, 12, 325.
https://doi.org/10.3390/vaccines12030325
AMA Style
Bartolomeo R, Troise F, Allocca S, Sdruscia G, Vitale R, Bignone V, Petrone AM, Romano G, D’Alise AM, Ruzza V,
et al. Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines. 2024; 12(3):325.
https://doi.org/10.3390/vaccines12030325
Chicago/Turabian Style
Bartolomeo, Rosa, Fulvia Troise, Simona Allocca, Giulia Sdruscia, Rosa Vitale, Veronica Bignone, Anna Maria Petrone, Giuseppina Romano, Anna Morena D’Alise, Valentino Ruzza,
and et al. 2024. "Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine" Vaccines 12, no. 3: 325.
https://doi.org/10.3390/vaccines12030325
APA Style
Bartolomeo, R., Troise, F., Allocca, S., Sdruscia, G., Vitale, R., Bignone, V., Petrone, A. M., Romano, G., D’Alise, A. M., Ruzza, V., Garzia, I., Leoni, G., Merone, R., Lanzaro, F., Colloca, S., Siani, L., Scarselli, E., & Cotugno, G.
(2024). Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine. Vaccines, 12(3), 325.
https://doi.org/10.3390/vaccines12030325
